Lisata Therapeutics

Lisata Therapeutics, Inc., founded in New York, is a global biopharmaceutical company dedicated to developing innovative therapies for cardiovascular and autoimmune diseases. The company's core mission is to address high unmet medical needs through targeted therapy and rigorous data application. Lisata's product offerings include the CendR Platform® Technology, which enhances the delivery of anti-cancer drugs to solid tumors and targets non-cancerous, immunosuppressive cells, thereby improving treatment efficacy.

Notable figures associated with Lisata Therapeutics include leading scientists and industry experts who contribute to its research and development efforts. The company has attracted significant investment from prominent venture capital firms, underscoring confidence in its potential. Key achievements include advancing multiple clinical-stage therapies and demonstrating promising results in early trials. Lisata's impact is reflected in its commitment to transforming patient outcomes through cutting-edge biopharmaceutical innovations.